Showing results (271-280 of 355) with videos related to

Sort By:
Pageof 36
JAMA Cardiology|November 17, 2024
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical TrialsAnkeet S Bhatt, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
Circulation|March 9, 2026
Differences in Disease Trajectory, Comorbidities, and Mortality in Sarcomeric and Nonsarcomeric Hypertrophic CardiomyopathyChristoffer R Vissing, Anna Axelsson Raja, Adam S Helms, et al.
European Journal of Heart Failure|April 11, 2026
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF TrialYasuhiro Hamatani, John W Ostrominski, Henri Lu, et al.
Circulation. Heart Failure|August 27, 2022
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER TrialAlexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 29, 2024
Effectiveness of high-dose versus standard-dose quadrivalent influenza vaccine against recurrent hospitalizations and mortality in relation to influenza circulation: A post-hoc analysis of the DANFLU-1 randomized clinical trialNiklas Dyrby Johansen, Daniel Modin, Kristoffer Grundtvig Skaarup, et al.
Journal of the American College of Cardiology|August 27, 2023
Dapagliflozin in Patients With Heart Failure and Deterioration in Renal FunctionSafia Chatur, Muthiah Vaduganathan, Brian L Claggett, et al.
JAMA Cardiology|November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical TrialFinnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Journal of the American College of Cardiology|September 1, 2024
Impact of Aficamten on Echocardiographic Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic CardiomyopathySheila M Hegde, Brian L Claggett, Xiaowen Wang, et al.
European Journal of Heart Failure|November 7, 2022
Dapagliflozin in patients with heart failure with mildly reduced and preserved ejection fraction treated with a mineralocorticoid receptor antagonist or sacubitril/valsartanMingming Yang, Jawad H Butt, Toru Kondo, et al.
European Heart Journal Open|January 15, 2026
Electronic nudges to increase influenza vaccination uptake in younger and middle-aged individuals with atrial fibrillation: a prespecified analysis of the NUDGE-FLU-CHRONIC trialCaroline Espersen, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
Pageof 36